Edwards Lifesciences Stock News

IFM Investors Pty Ltd decreased its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 0.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 83,214 shares of the medical research companys stock after selling 245 shares during the quarter. IFM Investors Pty []

Wesbanco Bank Inc. acquired a new position in Edwards Lifesciences Co. (NYSE:EW) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 11,622 shares of the medical research companys stock, valued at approximately $1,316,000. Several other hedge funds and other institutional investors []

Renaissance Technologies LLC cut its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 97.4% during the second quarter, HoldingsChannel.com reports. The fund owned 8,100 shares of the medical research companys stock after selling 299,900 shares during the quarter. Renaissance Technologies LLCs holdings in Edwards Lifesciences were worth $839,000 at the end of the most []

Edwards Lifesciences Co. (NYSE:EW) has been given an average rating of Buy by the twenty-one ratings firms that are covering the firm, Marketbeat.com reports. Nine investment analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have updated []

Veriti Management LLC lifted its holdings in Edwards Lifesciences Co. (NYSE:EW) by 1.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,691 shares of the medical research companys stock after buying an additional 116 shares during the period. []

Wedbush Securities Inc. boosted its position in shares of Edwards Lifesciences Co. (NYSE:EW) by 2.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,013 shares of the medical research companys stock after purchasing an additional 518 shares during the []

West Oak Capital LLC bought a new stake in Edwards Lifesciences Co. (NYSE:EW) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 300 shares of the medical research companys stock, valued at approximately $34,000. Several other large investors have also recently []

TPG Financial Advisors LLC grew its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 17.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,486 shares of the medical research companys stock after buying an additional 524 shares []

Investors are optimistic about Edwards Lifesciences (EW) on strong third-quarter results and bullish 2021 guidance.

Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q3 2021 Results - Earnings Call Transcript

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 1.89% and -0.92%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

IRVINE, Calif., Oct. 20, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2021 after the market closes on Wednesday, Oc

OCPNY vs. EW: Which Stock Is the Better Value Option?

Michael Mussallem, Chairman And CEO at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A Form 4 filing from the

The GuruFocus business predictability rating ranks companies on a five-star scale, defining the more predictable companies as businesses whose revenue per share and Ebitda per share have been growing